International Journal of Biological Macromolecules, Год журнала: 2024, Номер 281, С. 136290 - 136290
Опубликована: Окт. 9, 2024
Язык: Английский
International Journal of Biological Macromolecules, Год журнала: 2024, Номер 281, С. 136290 - 136290
Опубликована: Окт. 9, 2024
Язык: Английский
Naunyn-Schmiedeberg s Archives of Pharmacology, Год журнала: 2024, Номер 397(12), С. 10091 - 10107
Опубликована: Июль 9, 2024
Abstract Eight Novel chalcones were synthesized and their structures confirmed by different spectral tools. All the prepared compounds subjected to SRB cytotoxic screening against several cancer cell lines. Compound 5c exerted most promising effect MCF7 HEP2 cells with IC 50 values of 9.5 12 µg/mL, respectively. Real-time PCR demonstrated inhibitory compound on expression level Antigen kiel 67 (KI-67), Survivin, Interleukin-1beta ( IL-1B ) , Interleukin-6 IL-6 ), Cyclooxygenase-2 (COX-2 Protein kinase B (AKT1) genes. Flow-cytometric analysis cycle indicated that stopped at G0/G1 G2/M phases in treated cells, ELISA assay showed Caspase 8, 9, P53, BAX, Glutathione (GSH) extremely activated Matrix metalloproteinase 2 (MMP2), 9 (MMP9), BCL2, Malondialdehyde (MDA), deactivated cells. Wound healing revealed chalcone reduced ability close scrape wound decreased number migrating compared untreated after 48 h. Theoretical molecular modeling P53 mutant Y220C Bcl2 binding energies -22.8 -24.2 Kcal/mole, respectively, which our results.
Язык: Английский
Процитировано
8Scientific Reports, Год журнала: 2024, Номер 14(1)
Опубликована: Ноя. 4, 2024
Язык: Английский
Процитировано
6Asian Journal of Chemistry, Год журнала: 2025, Номер 37(4), С. 893 - 908
Опубликована: Март 29, 2025
A series of (E)-2-(2-(anthracen-9-ylmethylene)hydrazinyl)-4-(pyrrolidin-1-ylmethyl)thiazole (7a-l) were synthesized and evaluated for their in vitro anticancer activity against three human cancer cell lines MCF-7 (breast), A549 (lung) HepG2 (liver). In this study, cisplatin served as the positive control. The results showed that compounds 7c, 7g, 7i, 7j 7l demonstrated promising all lines. Notably, compound exhibited higher than standard drug MCF-7, HepG2, with IC50 values 9.08 ± 0.32 µM, 5.92 1.16 µM 6.96 0.13 respectively. Molecular docking studies 7i DNA topoisomerase II (PDB ID:3QX3) indicated strong affinity toward target protein. Moreover, an silico pharmacokinetic profile was generated using SWISS/ADMET pkCSM. Furthermore, found to comply Lipinski, Ghose, Veber, Egan Muegge rules. Based on results, characterized by density functional theory (DFT) studies.
Язык: Английский
Процитировано
0Journal of Molecular Structure, Год журнала: 2025, Номер unknown, С. 142345 - 142345
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Results in Chemistry, Год журнала: 2024, Номер 10, С. 101726 - 101726
Опубликована: Авг. 1, 2024
Язык: Английский
Процитировано
3ARKIVOC, Год журнала: 2024, Номер 2024(8)
Опубликована: Июль 4, 2024
New thiazolo[3',2':1,2]pyrimido [4,5-b]quinolines were synthesized in good yields using a three-component Hantzsch reaction comprising the appropriate aldehyde and one mole each of 6-aminothiouracil 5,5dimethyl-1,3-cyclohexanedione.The identical compounds might also be generated by alkylating relevant 5-aryl-2-thioxopyrimido[4,5-b]quinoline-4,6-diones with matching 2-chloro-N-arylacetamide.A feasible mechanistic approach to production target products was proposed.
Язык: Английский
Процитировано
1International Journal of Biological Macromolecules, Год журнала: 2024, Номер 281, С. 136290 - 136290
Опубликована: Окт. 9, 2024
Язык: Английский
Процитировано
1